18 Jun (ALLIANCE FOR NATURAL HEALTH) – It’s time to take the BPA fight to the state legislatures. Three recent studies paint a bleak picture about both the health risks and the prevalence of bisphenol A (BPA), a known endocrine disruptor. A Dutch study has found that fetuses of mothers who have high levels of BPA in their systems grow more slowly, have smaller heads, and weigh 20% less at birth compared with babies born to women with the lowest BPA levels.
Moreover, BPA may have multigenerational effects. A study published in the peer-reviewed journal Endocrinology demonstrated that exposure to even very low levels of BPA during pregnancy results in adverse behavioral effects in mice carried forward over three generations. The multi-generational effects result from an epigenetic mechanism.
In a third study, children and adolescents with high levels of urinary BPA showed evidence of low-grade albuminuria (where the kidney has experienced damage and is starting to spill some albumin into the urine). Damage at this early stage may have implications for the later development of kidney and cardiovascular disease.
Despite growing evidence to the contrary, FDA’s assessment is that BPA is safe at low levels. The FDA rejected a petition from the Natural Resources Defense Council to ban BPA in food containers. ANH-USA’s petition to the Consumer Protection Agency was denied, and they still haven’t received a response to their OSHA petition regarding BPA in thermal register receipts.
Given the federal government’s inaction, if we are to make progress on BPA, it will have to occur at the state level. This approach has already created positive change: the chemical industry voluntarily petitioned the FDA to limit BPA in baby food containers—and of course, since it came from the chemical industry, the FDA listened without commenting on the question of safety!
For complete article and related BPA bills go to ANH.